Hydroxyurea Capsules 500 mg and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Hydroxyurea Capsules 500 mg and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyurea
Brand name: Droxia, Hydrea, Mylocel, Siklos
Synonyms: Hydroxyurea
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyurea Capsules 500 mg-Insulin degludec
- Hydroxyurea Capsules 500 mg-Insulin Degludec (U-100) Prefilled Pens
- Hydroxyurea Capsules 500 mg-Insulin Degludec (U-100) Vials
- Hydroxyurea Capsules 500 mg-Insulin Degludec (U-200) Prefilled Pens
- Hydroxyurea Capsules 500 mg-Insulin degludec and liraglutide
- Hydroxyurea Capsules 500 mg-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hydroxyurea Tablets
- Insulin aspart, recombinant Subcutaneous-Hydroxyzine
- Insulin aspart, recombinant Subcutaneous-Hydroxyzine Capsules
- Insulin aspart, recombinant Subcutaneous-Hydroxyzine Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Hydroxyzine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Hydroxyzine Injection